Form 4: OPKO Health CEO Phillip Frost Acquires 125,000 Shares in Open Market Purchase

Sentiment:

SEC Form 4 Filing


OPKO Health's CEO and Chairman, Phillip Frost, through related entities, acquired 125,000 shares of common stock in a series of transactions on December 13, 2024.

Summary

  • Phillip Frost, CEO and Chairman of OPKO Health, acquired 125,000 shares of OPKO common stock on December 13, 2024.
  • The shares were purchased at a weighted average price of $1.595, with individual transactions ranging from $1.585 to $1.605.
  • The purchase was made through Frost Gamma Investments Trust, of which Phillip Frost is the trustee.
  • Following the transaction, Frost's indirect holdings through Frost Gamma Investments Trust are 212,536,477 shares.
  • Frost also has direct holdings of 3,568,951 shares and indirect holdings through Frost Nevada Investments Trust of 30,127,177 shares.

Sentiment

Score: 6

Explanation: The document reflects a routine insider purchase, which is generally neutral to slightly positive. The CEO's investment can be seen as a sign of confidence, but it's not a major event.

Positives

  • The CEO's purchase of shares can be seen as a positive signal of confidence in the company's future prospects.
  • The purchase increases the CEO's stake in the company, aligning his interests with those of other shareholders.

Risks

  • The document does not indicate any specific risks associated with the transaction.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific industry trends.

Comparison to Industry Standards

  • Insider trading activity is a common occurrence in publicly traded companies, and this transaction is within the normal range of such activities.
  • The filing is consistent with SEC regulations for reporting changes in beneficial ownership.

Stakeholder Impact

  • The share purchase may have a slightly positive impact on shareholder sentiment due to the CEO's increased investment.

Key Dates

DateDescription
12/13/2024Date of the share purchase transaction.

Keywords

OPKO Health, Phillip Frost, insider trading, share purchase, common stock, Frost Gamma Investments Trust, Frost Nevada Investments Trust, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.